PE-Labeled MSLN Fc&Avi Tag: The "Multitasking Special Platform" for Targeted Solid Tumor Therapy

Author: Senior Product Manager of UA Views：428

PE-Labeled MSLN Fc&Avi Tag is a modular, multifunctional core probe designed for the critical tumor-associated antigen mesothelin.

Recent Advances
Product Information

Recent Advances

PE-Labeled MSLN Fc&Avi Tag is a modular, multifunctional core probe designed for the key tumor-associated antigen mesothelin. Mesothelin is a glycosylphosphatidylinositol-anchored cell surface glycoprotein that is expressed at low levels in normal mesothelial tissues but is abnormally overexpressed in various aggressive solid tumors, including malignant mesothelioma, pancreatic ductal adenocarcinoma, ovarian cancer, and certain lung cancers. This probe integrates MSLN's targeting domain with a PE fluorescent "main gun," an Fc universal "tactical interface," and an AviTag biotinylation "expansion dock" to create a comprehensive "special operations platform" capable of ultra-high-sensitivity detection, functional receptor manipulation, and on-demand customization. It serves as a core support for basic research, precision diagnosis, and next-generation therapy development for MSLN-related tumors.

I. Overview: Strategic Modular Design

This protein is an "all-in-one" tool platform built on cutting-edge protein engineering principles, designed to maximize the potential of MSLN as a tumor target.

MSLN Extracellular Domain Targeting Module

The core of the probe is the mature extracellular domain of human mesothelin protein. This domain retains the biological activity for binding to natural ligands and various therapeutic antibodies (e.g., Amatuximab), enabling high-affinity, calcium-dependent recognition of MSLN antigens on tumor cell surfaces. Its overexpression in tumors is closely associated with poor patient prognosis.

Fc Tag

The fused immunoglobulin Fc fragment serves as a "tactical hub" in this platform:

Universal Signal Conversion and Amplification: Provides a universal binding site for any anti-Fc secondary antibody conjugate. This allows researchers to freely "project" detection signals into different fluorescence channels of flow cytometers or imaging systems, or achieve exponential signal amplification through multi-step cascading reactions, particularly useful for detecting微量 samples or low-expression targets.

Induction of Functional Receptor Crosslinking: By adding anti-Fc antibodies, artificial clustering of MSLN can be induced on cell surfaces, enabling studies on the effects of receptor crosslinking on downstream signaling and endocytosis dynamics, or serving as an in vitro model for evaluating antibody-dependent cell-mediated cytotoxicity.

AviTag

A short peptide tag that can be specifically biotinylated by biotin ligase, serving as the platform's "strategic expansion interface":

Unlimited Functional Derivatization Capability: After biotinylation, the probe can be rapidly and directionally conjugated with any streptavidin/avidin-functionalized module (e.g., different fluorescent dyes, magnetic beads, enzymes, radionuclides, drug toxins) via ultra-strong binding, achieving "one core, versatile applications."

PE Direct Labeling

The probe is pre-conjugated with R-phycoerythrin, providing powerful initial "firepower":

Ensures Overwhelming Signal-to-Noise Ratio in Basic Detection: PE's extreme brightness enables clear identification of MSLN-positive cells against complex backgrounds in direct staining applications, making it the preferred solution for flow cytometry detection of rare cell populations (e.g., circulating tumor cells) or rapid screening.

Platform Positioning

This probe is a "trinity" tactical platform. PE serves as the "main combat unit" for direct, powerful reconnaissance and labeling; the Fc tag acts as a "standardized command link" coordinating various support and协同 operations; and the AviTag is a "forward supply and modification interface" that can随时接入特种装备 (imaging, sorting, therapeutic payloads). Together, they ensure full-chain, configurable research capabilities for MSLN targets, from "discovery" to "intervention."

II. Core Mechanisms: Flexible Multi-Mode Operational Capabilities

This platform supports a series of "operational modes," from basic detection to advanced functional research.

1. Direct Assault Detection Mode

PE Ultra-Bright Direct Labeling: No secondary antibody required; one-step of MSLN-positive cells. PE's powerful signal is especially suitable for rapid identification and counting of tumor cells in clinical samples (e.g., malignant pleural effusions, ascites, blood) or high-throughput preliminary screening of tissue arrays.

Resolving Multicolor Panel Conflicts: When the PE channel in a multicolor experiment is occupied by other critical markers, an unlabeled PE version can be used first, followed by an anti-Fc secondary antibody conjugated to APC, BV711, or other dyes to "transfer" the MSLN signal to other channels, enabling flexible design of ultra-high-parameter flow cytometry panels.

Cascade Amplification of Weak Signals: For samples with extremely low expression levels or antigen downregulation after drug treatment, a multi-step method ("probe + biotinylated anti-Fc secondary antibody + streptavidin-fluorescence complex") can be employed to achieve极致 signal amplification.

2. Functional Interference and Manipulation Mode

Simulating Therapeutic Antibody Effects: Utilizing its Fc fragment, anti-Fc antibodies can induce MSLN receptor crosslinking and internalization,antibody drugs (e.g., Anetumab ravtansine), studying their impact on tumor cell signaling, survival, and drug endocytosis.

Competitive Binding and Blocking: As a soluble high-affinity receptor, it can competitively block the binding of therapeutic antibodies or CAR-T cells to tumor cells,

3. On-Demand Customization Mode

Rapid Generation of Specialized Tools: Through AviTag biotinylation, the platform core can be converted within one hour into probes for in vivo near-infrared imaging, magnetic bead conjugates for cell sorting, or targeted capture reagents for drug screening, significantly enhancing研发 efficiency.

III. Downstream Applications: Spanning Oncology Research and Clinical Practice

This platform holds pivotal value in the research, diagnosis, and therapeutic development of MSLN-positive malignancies.

1. Tumor Diagnosis and Liquid Biopsy

Malignant Effusion Differential Diagnosis: In pleural effusion or ascites samples,PE's high brightness, flow cytometry can rapidly and specifically鉴别 MSLN-positive tumor cells, aiding in distinguishing malignant mesothelioma, ovarian cancer metastasis, and reactive hyperplasia, with significant clinical implications.

Circulating Tumor Cell Enrichment and Molecular Subtyping: High-sensitivity enrichment of MSLN-positive CTCs from pancreatic or ovarian cancer patient peripheral blood, combined with single-cell sequencing to analyze genomic variations, enables real-time monitoring of tumor evolution, assessment of metastatic potential, and treatment response.

2. Tissue Pathology Analysis and Biomarker Research

Tumor Microenvironment Spatial Resolution: Used for multiplex immunofluorescence staining to simultaneously visualize MSLN+ tumor cells and CD8+ T cells, PD-L1+ cells, CAFs, etc., in situ, revealing the cellular basis of immune exclusion or desert-type phenotypes.

Prognostic and Predictive Biomarker Evaluation: On tissue microarrays, quantitative analysis of MSLN expression levels, heterogeneity, and their association with stromal components can assess its potential as a prognostic marker or predictive biomarker for ADC/CAR-T efficacy.

3. Development and Evaluation of Novel MSLN-Targeted Therapies

"Swiss Army Knife" for ADC Drug Development:

Target Validation and Endocytosis Studies: tumor cell lines or patient-derived models for MSLN expression density and uniformity, and visualizing the binding and endocytosis kinetics of ADC drug models (e.g., simulated via Fc or AviTag), optimizing drug design.

Pharmacodynamic Biomarkers: In preclinical models, this probe can monitor changes in MSLN expression on tumor cells before and after treatment, predicting and studying antigen loss-mediated resistance.

End-to-End Tool for CAR-T Cell Therapy:

Patient Screening: Standardized detection of tumor MSLN expression is a critical step for CAR-T clinical trial enrollment.

Efficacy Monitoring and Escape Mechanism Research: Dynamic monitoring of MSLN-positive tumor cell clearance in patients and investigating

Bispecific Antibody and Vaccine Evaluation: As a standardized target antigen, it can be used to evaluate the binding and activation efficiency of novel bispecific antibodies or as an antigen source for DC vaccine functional validation.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose Nanjing UA-Bio

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UA Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next